LIPO stock news
US Markets

Lipella Pharmaceuticals (NASDAQ: LIPO) Stock Skyrockets as Phase 2a Trial for LP-310 Kicks Off

/

Lipella Pharmaceuticals (NASDAQ: LIPO) saw its stock more than double during intraday trading following the Phase 2a trial initiation for […]

Lipella Pharmaceuticals (NASDAQ: LIPO) Stock Skyrockets as Phase 2a Trial for LP-310 Kicks Off Read More »